Depression and substance use comorbidity: What we have learned from animal studies.
Depression and substance use disorders are often comorbid, but the reasons for this are unclear. In human studies, it is difficult to determine how one disorder may affect predisposition to the other and what the underlying mechanisms might be. Instead, animal studies allow experimental induction of behaviors relevant to depression and drug-taking, and permit direct interrogation of changes to neural circuits and molecular pathways. While this field is still new, here we review animal studies that investigate whether depression-like states increase vulnerability to drug-taking behaviors. Since chronic psychosocial stress can precipitate or predispose to depression in humans, we review studies that use psychosocial stressors to produce depression-like phenotypes in animals. Specifically, we describe how postweaning isolation stress, repeated social defeat stress, and chronic mild (or unpredictable) stress affect behaviors relevant to substance abuse, especially operant self-administration. Potential brain changes mediating these effects are also discussed where available, with an emphasis on mesocorticolimbic dopamine circuits. Postweaning isolation stress and repeated social defeat generally increase acquisition or maintenance of drug self-administration, and alter dopamine sensitivity in various brain regions. However, the effects of chronic mild stress on drug-taking have been much less studied. Future studies should consider standardizing stress-induction protocols, including female subjects, and using multi-hit models (e.g. genetic vulnerabilities and environmental stress).
a Lunenfeld-Tanenbaum Research Institute , Mount Sinai Hospital , Toronto , Canada.|b Institute of Medical Science, University of Toronto , Toronto , Canada.
Enoch
E
Ng
c Department of Psychology , University of Toronto , Toronto , Canada.|d Campbell Family Health Institute , Centre for Addiction and Mental Health , Toronto , Canada.
Caleb J
CJ
Browne
d Campbell Family Health Institute , Centre for Addiction and Mental Health , Toronto , Canada.|e Department of Pharmacology , University of Toronto , Toronto , Canada.
James N
JN
Samsom
b Institute of Medical Science, University of Toronto , Toronto , Canada.|d Campbell Family Health Institute , Centre for Addiction and Mental Health , Toronto , Canada.|e Department of Pharmacology , University of Toronto , Toronto , Canada.|f Department of Psychiatry , University of Toronto , Toronto , Canada.
Albert H C
AHC
Wong
D000818:Animals; D001522:Behavior, Animal; D001921:Brain / Q000378:metabolism; D003863:Depression / Q000150:complications* / Q000453:epidemiology / Q000503:physiopathology; D017831:Diagnosis, Dual (Psychiatry); D004195:Disease Models, Animal; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D012646:Self Administration; D013315:Stress, Psychological / Q000150:complications / Q000523:psychology; D019966:Substance-Related Disorders / Q000150:complications* / Q000453:epidemiology / Q000503:physiopathology
D004298:Dopamine
Depression; animal model; chronic mild stress; comorbidity; dual diagnosis; isolation stress; social defeat stress; substance use